InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

38
Insider
Date
Role
Action
Shares
Price
Amount
Acorn Bioventures, L.p.
15 May 2025
10% owner
Buy indirect
1,129,730
$1.85
$2.09M
Acorn Bioventures, L.p.
15 May 2025
10% owner
Buy
270,270
$1.85
$500.00K
Braden Michael Leonard
25 Sep 2024
10% owner
Buy indirect
68,746
$1.50
$102.87K
Braden Michael Leonard
24 Sep 2024
10% owner
Buy indirect
29,600
$1.41
$41.87K
Braden Michael Leonard
18 Sep 2024
10% owner
Buy indirect
806
$1.40
$1.13K
Braden Michael Leonard
17 Sep 2024
10% owner
Buy indirect
55,300
$1.36
$75.11K
Braden Michael Leonard
16 Sep 2024
10% owner
Buy indirect
172,747
$1.37
$236.87K
Braden Michael Leonard
13 Sep 2024
10% owner
Buy indirect
150,000
$1.31
$196.95K
Braden Michael Leonard
12 Sep 2024
10% owner
Buy indirect
36,176
$1.40
$50.52K
Braden Michael Leonard
14 Aug 2024
10% owner
Buy indirect
100,487
$1.41
$142.01K
Braden Michael Leonard
13 Aug 2024
10% owner
Buy indirect
171,339
$1.39
$238.59K
Braden Michael Leonard
14 May 2024
10% owner
Buy indirect
335,000
$1.54
$515.90K
Braden Michael Leonard
14 May 2024
10% owner
Buy indirect
79,281
$1.56
$123.68K
Niall O'Donnell
8 May 2023
Director
Buy indirect
125,000
$8.00
$1.00M
Michael Cruse
1 Sep 2022
Chief Operating Officer
Buy indirect
7,500
$3.39
$25.45K
Michael Cruse
31 Aug 2022
Chief Operating Officer
Buy indirect
3,212
$3.21
$10.31K
Michael Cruse
30 Aug 2022
Chief Operating Officer
Buy indirect
1,845
$3.19
$5.89K
Michael Cruse
30 Aug 2022
Chief Operating Officer
Buy
975
$3.16
$3.08K
Michael Cruse
29 Aug 2022
Chief Operating Officer
Buy indirect
1,140
$3.24
$3.69K
Michael Cruse
29 Aug 2022
Chief Operating Officer
Buy
83
$3.24
$268.92
Michael Cruse
25 Aug 2021
Senior VP-Corporate Operations
Buy
2,500
$7.45
$18.62K
Gregory J. Flesher
25 Aug 2021
President and CEO
Buy
8,000
$8.00
$64.00K
Vineet R. Jindal
25 Aug 2021
Chief Financial Officer
Buy
5,000
$7.44
$37.18K
Bali Muralidhar
14 Jul 2021
Director
Buy indirect
111,736
$8.50
$949.76K
Bali Muralidhar
23 Jun 2021
Director
Buy indirect
20,710
$9.28
$192.24K
Bali Muralidhar
22 Jun 2021
Director
Buy indirect
14,615
$8.72
$127.49K
Bali Muralidhar
21 Jun 2021
Director
Buy indirect
32,659
$9.03
$294.93K
Bali Muralidhar
8 Jun 2021
Director
Buy indirect
16,605
$9.50
$157.71K
Bali Muralidhar
4 Jun 2021
Director
Buy indirect
257
$9.42
$2.42K
Bali Muralidhar
3 Jun 2021
Director
Buy indirect
12,100
$9.25
$111.94K
Bali Muralidhar
28 May 2021
Director
Buy indirect
14
$9.50
$133.00
Bali Muralidhar
27 May 2021
Director
Buy indirect
1,120
$9.26
$10.37K
Bali Muralidhar
26 May 2021
Director
Buy indirect
5,915
$9.38
$55.50K
Novo Holdings A/S
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
Bali Muralidhar
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
Niall O'Donnell
13 Apr 2021
Director
Buy indirect
200,000
$15.00
$3.00M
New Enterprise Associates 15, L.P.
13 Apr 2021
10% owner
Buy
666,666
$15.00
$10.00M
RiverVest Venture Fund III, L.P.
9 Apr 2021
10% owner
Buy indirect
200,000
$15.00
$3.00M
Show all 61 transactions →

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021